How PBI/Gordon Companies leveraged our Sirolimus API Market report
VM Intelligence · Sample preview · Healthcare and Pharmaceuticals · Forecast 2027–2033
Transitional Care Management (TCM) Services Market
- By Service Type: Post-Discharge Follow-Up, Medication Reconciliation, Patient Education and Counseling, Care Coordination, Home Health Visits
- By Provider Type: Primary Care Physicians, Specialist Physicians, Nurse Practitioners, Physician Assistants, Home Health Agencies
- By Patient Setting: Hospital Discharge, Skilled Nursing Facility Discharge, Home Health Care, Outpatient Clinics
- By Payer Type: Medicare, Medicaid, Private Insurance, Self-Pay
- By Communication Mode: Telephonic Follow-Up, In-Person Visits, Telehealth/Virtual Care, Electronic Health Record (EHR) Based Coordination
Key Highlights
A snapshot of what the full report proves- 01 Market size - $X,XXX.XM global market in 2025 - the verified base-year revenue. Executive Summary →
- 02 Forecast - Full 2033 market projection modelled inside - unlock the forecast value to see where the market lands. Market Outlook →
- 03 Growth - Year-by-year CAGR across 2027–2033 - unlock the growth rate and the full model. Market Outlook →
- 04 Leading segment - Post-Discharge Follow-Up leads By Service Type at XX% share. Market, by Service Type →
- 05 Global coverage - Sized across 5 regions and 20 countries, each broken out by segment. Market, by Geography →
- 06 Competitive landscape - 15 companies profiled with SWOT, benchmarking and market-share analysis. Company Profiles →
Inside the Report
12 chapters · 298 pages- 01 Introduction Definition, segmentation & scope p.12 →
- 02 Research Methodology How the numbers were built p.20 →
- 03 Executive Summary The market in one chapter p.34 →
- 04 Market Outlook Drivers, restraints, trends p.66 →
- 11 Competitive Landscape 5 sections p.180 →
- 12 Company Profiles 15 players: SWOT & benchmarking p.188 →
Full report · locked preview
Everything inside the Transitional Care Management (TCM) Services Market report
A complete, evidence-based study - 12 chapters and 125 sections covering market size, segmentation across 5 axes, regional analysis and 15 company profiles, forecast to 2033.
Segmentation covered
Service Type 5
Provider Type 5
Patient Setting 4
Payer Type 4
Communication Mode 4
Companies profiled
UnitedHealth Group
CVS Health
Anthem Inc.
Cigna Corporation
Humana Inc.
Centene Corporation
Molina Healthcare
Aetna (a CVS Health company)
Optum (a part of UnitedHealth Group)
Magellan Health
Envolve PeopleCare
WellCare Health Plans (a Centene company)
+3 more
Verified · Analyst-reviewed · No payment to preview
Trusted & certified by
★★★★★ Excellent
★★★★★ Excellent
15 players profiled - tiered by revenue contribution, footprint and R&D capability.
ACE Matrix · p.153 →UnitedHealth Group
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.155 →CVS Health
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.160 →Anthem Inc.
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.166 →Cigna Corporation
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.173 →Humana Inc.
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.178 →Centene Corporation
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.184 →Molina Healthcare
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking · Segment breakdown
Full profile · p.191 →Aetna (a CVS Health company)
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.196 →Optum (a part of UnitedHealth Group)
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.202 →Magellan Health
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking · Segment breakdown
Full profile · p.209 →Envolve PeopleCare
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.214 →WellCare Health Plans (a Centene company)
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.220 →DaVita Inc.
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.227 →Kindred Healthcare (a Humana company)
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.232 →LHC Group
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.238 →Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Global · 2025–2033
$6,729M by 2033 · 5.7% CAGR
Market estimates & forecast (USD Million)
Fig. 15 · p.34 →Segment mix, 2033 (% share)
Fig. 16 · p.35 →- Post-Discharge Follow-Up48.3
- Medication Reconciliation14.1
- Patient Education and Counseling7.8
- Care Coordination10.8
- Home Health Visits19.1
Regions, 2025 → 2033 (USD Mn)
§6.1 · p.75 →North America$1,424M → $2,131M · 5.2%
Europe$992.4M → $1,632M · 6.4%
Asia Pacific$906.1M → $1,586M · 7.2%
Latin America$560.9M → $829.9M · 5.0%
Middle East and Africa$431.5M → $737.6M · 6.9%
Top countries, 2033 (USD Mn)
§6.2 · p.78 →Year-over-year growth (%)
§3.12 · p.44 →5.672026
5.672027
5.682028
5.692029
5.712030
5.732031
5.732032
5.742033
CAGR by region (%)
Fig. 22 · p.71 →Market share by company, 2033 (%)
Fig. 41 · p.152 →- UnitedHealth Group14.3
- CVS Health23.0
- Anthem Inc.11.0
- Cigna Corporation6.2
- Humana Inc.6.7
- Centene Corporation10.9
- Others27.9
Segment contribution to growth (%)
Fig. 18 · p.39 →Service Type9.9%
Provider Type17.7%
Patient Setting23.7%
Payer Type24.4%
Communication Mode24.4%
Competitive positioning (ACE matrix)
Fig. 40 · p.153 →Adoption & penetration (% of addressable)
Fig. 12 · p.31 →Revenue by application (USD Mn)
§5.3 · p.62 →Demand by end-use (USD Mn)
§5.4 · p.66 →Average selling price trend (index, 2025=100)
Fig. 27 · p.58 →Top companies by revenue, 2033 (USD Mn)
Fig. 42 · p.155 →Revenue by region, 2033 (%)
Fig. 20 · p.70 →- North America30.8
- Europe23.6
- Asia Pacific22.9
- Latin America12.0
- Middle East and Africa10.7
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
8 players benchmarked across 6 dimensions — scored 0–100 from share, portfolio, reach, innovation, financials and installed base. Methodology · §8.1 · p.160 →
Competitive scorecard (score 0–100)
Table 31 · p.161 →| Company | Market share | Product portfolio | Geographic reach | Innovation & R&D | Financial strength | Customer base | Composite |
|---|---|---|---|---|---|---|---|
| UnitedHealth Group | 93 | 85 | 75 | 92 | 74 | 95 | 86 |
| CVS Health | 70 | 84 | 86 | 78 | 81 | 70 | 78 |
| Anthem Inc. | 74 | 87 | 79 | 71 | 65 | 70 | 74 |
| Cigna Corporation | 67 | 65 | 82 | 74 | 68 | 65 | 70 |
| Humana Inc. | 59 | 69 | 61 | 52 | 69 | 57 | 61 |
| Centene Corporation | 61 | 53 | 63 | 64 | 52 | 69 | 60 |
| Molina Healthcare | 46 | 64 | 65 | 51 | 40 | 64 | 55 |
| Aetna (a CVS Health company) | 43 | 58 | 51 | 60 | 48 | 41 | 50 |
Vendor positioning (presence × innovation)
Fig. 43 · p.163 →Strengths profile (top 3 players)
Fig. 44 · p.165 →- UnitedHealth Group
- CVS Health
- Anthem Inc.
Capability coverage
§8.3 · p.168 →| Company | Global delivery | R&D depth | Digital platform | Sustainability | After-sales | Custom solutions |
|---|---|---|---|---|---|---|
| UnitedHealth Group | ✓ | ✓ | ◐ | ◐ | ✓ | ◐ |
| CVS Health | ◐ | ✓ | ◐ | ✓ | ◐ | ◐ |
| Anthem Inc. | ✓ | ✓ | ◐ | ✓ | ◐ | ◐ |
| Cigna Corporation | − | ◐ | ◐ | ✓ | ◐ | − |
| Humana Inc. | ◐ | ◐ | − | ◐ | ◐ | − |
| Centene Corporation | ◐ | ◐ | ◐ | − | ◐ | − |
| Molina Healthcare | ◐ | ◐ | ✓ | − | − | ◐ |
| Aetna (a CVS Health company) | − | − | ◐ | − | ◐ | − |
✓ Full ◐ Partial − Limited
Overall competitive index (composite, ranked)
Fig. 45 · p.170 →1UnitedHealth Group86
2CVS Health78
3Anthem Inc.74
4Cigna Corporation70
5Humana Inc.61
6Centene Corporation60
7Molina Healthcare55
8Aetna (a CVS Health company)50
Competitive tiers
§8.4 · p.172 →Leader2
Set the pace on share, breadth and innovation.
UnitedHealth GroupCVS Health
Challenger2
Strong scale, closing on the leaders.
Anthem Inc.Cigna Corporation
Contender2
Focused players with pockets of strength.
Humana Inc.Centene Corporation
Niche2
Specialists in a single segment or region.
Molina HealthcareAetna (a CVS Health company)
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Go-to-market strategy
Land Service Type in North America, then scale across Transitional Care Management (TCM) Services Market — a $41M beachhead inside a $812M market.
Beachhead (SOM)$41Mobtainable near-term
Serviceable (SAM)$293Mreachable market
Primary motionPartner-led + digitalgo-to-market
Time to scale5 Qto full motion
Ideal customer profile (who to sell to)
§GTM 1 · p.190 →Champion91 fit
Post-Discharge Follow-Up
Best fit — highest urgency & budget in Service Type.
Economic buyer76 fit
Medication Reconciliation
Strong fit — clear ROI and a fast path to value.
End user66 fit
Patient Education and Counseling
Emerging fit — growing demand, longer sales cycle.
Market-entry sequence (beachhead → scale)
Fig. GTM 1 · p.192 →Beachhead · 2025–2026
Win Service Type in North America
Concentrated ICP, fastest proof and references.
Expand · 2026–2028
Add Provider Type & next regions
Repeat the motion in adjacent, look-alike segments.
Scale · 2028–2033
Full-market coverage + Patient Setting
Multi-channel, platform & ecosystem plays.
Channel mix (routes to market)
§GTM 3 · p.195 →Direct sales40%
Partner / channel29%
Digital / self-serve22%
Marketplaces9%
Positioning & messaging
§GTM 2 · p.194 →For Service Type leaders who need defensible market intelligence, VM Intelligence is the fastest, source-cited way to size, segment and win Transitional Care Management (TCM) Services Market — unlike generic, static research.
Live & source-cited
Every figure triangulated from 600K+ sources and traceable.
Ready in minutes
A full, tailored report compiled on demand — not weeks.
Scope you control
Pick the chapters, regions and companies that matter.
GTM funnel & unit economics (conversion · CAC / LTV)
Fig. GTM 2 · p.198 →Awareness100%
Marketing qualified39%
Sales qualified22%
Evaluation12%
Closed-won6%
$15.5KCAC
$78KLTV
5.0:1LTV : CAC
< 3 moCAC payback
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Investment thesis
Transitional Care Management (TCM) Services Market is a resilient opportunity — $7.26B by 2033, compounding at 5.8%.
TAM · 2025$4.63Btoday
TAM · 2033$7.26Bforecast
CAGR5.8%2027–2033
Cumulative$52.7Brevenue opportunity
Market opportunity (TAM · SAM · SOM)
Fig. 3 · p.14 →TAM$7.26BTotal addressable market
SAM$2.69BServiceable available market
SOM$480MServiceable obtainable market
Growth trajectory (USD Million)
Fig. 4 · p.16 →Why invest now
§2.1 · p.10 →5.8% CAGR
Demand compounds through 2033, outpacing GDP across Service Type.
Global tailwinds
North America leads today; fastest gains coming from emerging regions.
Structural shift
Adoption in Service Type moving from early to mainstream — durable secular demand.
Consolidation upside
15+ players, no runaway leader — room to build scale and roll up share.
Investment highlights
§2.2 · p.12 →$7.26BLarge & growingTAM by 2033 at 5.8% CAGR
$2.69BServiceable nowreachable with today’s model
$480MBeachhead winobtainable near-term share
15+Fragmented fieldplayers — consolidation runway
Return scenarios (2033 market value)
Fig. 6 · p.22 →$5.66BBear3.8% CAGR
$7.26BBase5.8% CAGR
$9.29BBull7.6% CAGR
Key risks & mitigants
§9.1 · p.180 →- Input-cost volatilityLong-term supply contracts & hedging
- Regulatory / policy shiftsDiversified exposure across 5 regions
- Technology disruptionR&D pipeline & Provider Type optionality
- Customer concentrationBroaden installed base beyond top accounts
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Board pack · executive summary
Transitional Care Management (TCM) Services Market — a $8.72B market by 2033. Plan: grow share from 5.6% to 12.3%.
Market size · 2033$8.72Btotal addressable
Market CAGR7.9%2027–2033
Target share12.3%from 5.6% today
Revenue ambition$1.07Bby 2033
Strategic scorecard (current vs 2033 target)
Table 1 · p.6 →| Objective | Current | Target · 2033 | Status |
|---|---|---|---|
| Market share | 5.6% | 12.3% | Ahead |
| Revenue | $502M | $1.07B | On track |
| Geographic coverage | 2 of 5 regions | 5 of 5 regions | At risk |
| Segment coverage | 3 of 5 axes | 5 of 5 axes | Ahead |
| Gross margin | 32.2% | 45.0% | On track |
| Customer retention | 85.4% | 95.0% | On track |
Where to play (strategic priorities)
§1.2 · p.8 →1
Lead segment
Win in Service Type
Largest revenue pool and fastest secular demand — concentrate to build share here first.
2
Geographic
Expand across North America & beyond
Deepen the leading region, then scale into the fastest-growing emerging markets.
3
Adjacency
Build Provider Type capability
A defensible second engine — invest in Provider Type to widen the moat and cross-sell.
Strategic roadmap (2025–2033)
Fig. 1 · p.10 →Phase 1 · Foundation
2025–2027
- Secure core Service Type share
- Fix unit economics
- Stand up data & ops
Phase 2 · Scale
2028–2030
- Enter new regions
- Launch Provider Type
- Selective M&A
Phase 3 · Lead
2031–2033
- Category leadership
- Premium mix & margin
- Platform & ecosystem
Board decisions & asks
§1.4 · p.14 →- Approve $127M capacity & capability investment
- Greenlight bolt-on M&A in Provider Type
- Authorise North America expansion plan
- Fund R&D program for Service Type leadership
Risk watchlist (RAG)
§9 · p.180 →- Demand / macro slowdownOn track
- Competitive share lossAt risk
- Input-cost & supply riskBehind
- Regulatory / policy changeAhead
- Execution & talentOn track
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Sales deck · value proposition
Win the Transitional Care Management (TCM) Services Market conversation — a $3.65B market you can size, segment and defend in minutes.
Market size · 2033$3.65Btotal opportunity
Growth6.2%CAGR to 2033
Addressable buyers1,221+accounts in scope
Typical ROI6×in year one
Who buys (target personas)
§1.1 · p.4 →Product / BU leader
Head of Service Type
Goal Grow share in Service Type
Pain Blind spots on demand, pricing & competitors.
Regional GM
North America lead
Goal Prioritise the right markets
Pain No granular, country-level view of the market.
M&A / strategy
Strategy & Corp Dev
Goal Find where to invest or acquire
Pain Slow, inconsistent third-party research.
From pain to solution
§1.2 · p.6 →Decisions made on stale, generic dataLive, source-cited figures, continuously updated
Weeks waiting on a research vendorA full report compiled in minutes
No view of competitors or whitespaceCompany profiles, ACE matrix & benchmarking
Hard to defend the numbers internallyEvery figure traceable to its original source
The business case (ROI)
Fig. 2 · p.9 →6×return on cost, year one
< 4 mopayback period
$93K+research cost avoided
10×faster than a custom study
Time to insight
Cost to run
Risk of a wrong call
Why buyers trust it (proof points)
§1.3 · p.12 →600K+source studies indexed
100%analyst-reviewed
15+players profiled in this market
Coverage includes
UnitedHealth GroupCVS HealthAnthem Inc.Cigna CorporationHumana Inc.Centene CorporationMolina HealthcareAetna (a CVS Health company)+7 more
Objection handling
§1.4 · p.14 →“We already have market data.”
This triangulates 600K+ sources into one current, defensible view — not another silo.
“How do we know it’s accurate?”
Analyst-reviewed, and every figure is source-cited and traceable to its origin.
“It’s not in the budget.”
A fraction of a single analyst-day — and it pays back on the first decision it informs.
“We need it tailored to us.”
Choose the chapters, regions and companies before you build — you only pay for scope.
What you get (packages)
§1.5 · p.16 →Report
- Full multi-chapter report
- Market size, share & forecast
- Segment & regional breakdowns
- PDF + editable Excel + PPT
Most popular
Report + Add-ons
- Everything in Report
- Interactive Visualizer
- Competitive benchmarking
- Investor / board / sales decks
Enterprise
- Multiple reports & markets
- Team seats & sharing
- Analyst support & custom scope
- API / data-feed options
Almost there
Access your Transitional Care Management (TCM) Services Market report
Sign in to unlock the full report - it’s compiled live and ready in minutes.
or continue with your email
Your report is ready to access
Transitional Care Management (TCM) Services Market Report is ready
Verify your email to unlock it. We sent a 6-digit code to your inbox.
That code is invalid or expired. Please try again.
Trusted by strategy, finance & consulting teams
Related Reports
Healthcare and Pharmaceuticals · scroll →Transitional Care Management Services Market
Market size, share, segmentation and regional forecast.
$3.0B market · 2025 base year
View reportTransillumination Vein Finder Market
Market size, share, segmentation and regional forecast.
$5.6B market · 2025 base year
View reportTransient Protein Expression Market
Market size, share, segmentation and regional forecast.
$3.9B market · 2025 base year
View reportTransient Absorption Spectrometer (TAS) Market
Market size, share, segmentation and regional forecast.
$2.2B market · 2025 base year
View reportTransglutaminase IgA ELISA Test Kit Market
Market size, share, segmentation and regional forecast.
$4.5B market · 2025 base year
View reportTransglutaminase Enzyme Market
Market size, share, segmentation and regional forecast.
$765M market · 2025 base year
View reportTransfusion Instrument Market
Market size, share, segmentation and regional forecast.
$1.7B market · 2025 base year
View reportTransfusion Dependent Thalassaemia Management Market
Market size, share, segmentation and regional forecast.
$4.6B market · 2025 base year
View reportTransfusion-dependent Anemia Treatment Market
Market size, share, segmentation and regional forecast.
$5.5B market · 2025 base year
View reportTransfusion Bottles Market
Market size, share, segmentation and regional forecast.
$4.1B market · 2025 base year
View reportTransfusion and Infusion Systems Market
Market size, share, segmentation and regional forecast.
$1.9B market · 2025 base year
View reportTransfer Stretcher Market
Market size, share, segmentation and regional forecast.
$4.4B market · 2025 base year
View reportThe showdown
Custom-built vs. off-the-shelf
Scroll to watch them go head-to-head
WinnerVMR Custom Report
- Tailored to your exact scope
- Delivered in minutes
- Live, always-current data
- Fully editable data (XLSX)
- You choose the companies
- Source-cited & traceable
Off-the-shelf PDF
- Generic, one-size template
- Waits 2–5 days
- A fixed snapshot in time
- Locked, flat PDF
- Preset company list
- Opaque sourcing
Customer Testimonials
Proof from industry leaders who rely on us
These stories come from the executives who depend on VMR’s intelligence for market entry, expansion, assessment, and planning. Their outcomes and experiences reflect our commitment to clarity.
600,000+source studies indexed
100%analyst-reviewed
Every figuresource-cited & traceable
In their words
Watch clients tell their story
How VMR helped University of Limerick with Anesthesia Monitoring Devices
How VMR helps brands expand into Africa & emerging markets
Unlock your GTM strategy: an Elsewedy Electric success story
Beyond sales data: layering NielsenIQ data to support strategy
How VMR became the trusted partner for United Alloy
Questions, answered
How is the research actually conducted?
Every report is compiled from VMR’s continuously-updated intelligence across 600,000+ source studies - primary interviews, company filings, trade data, and government & industry databases. Figures are triangulated across multiple credible sources, then reviewed by a research analyst before your report is delivered.
What exactly do I get inside the report?
A full multi-chapter study: market definition & methodology, executive summary, market outlook (drivers, restraints, trends, Porter’s Five Forces), segment deep-dives, regional & country breakdowns, competitive landscape, and a full profile for every company you select - with interactive charts and data tables throughout.
How accurate are the numbers, and can I trust them?
Market sizing is reconciled across leading sources (Gartner, BCG, MarketsandMarkets, government bodies and more), with outliers removed and a confidence-graded median used for the base year. Every figure is source-cited and traceable to its origin, and an analyst validates the model before delivery.
Can I customise the chapters, regions and companies?
Yes. Choose exactly the chapters, regions and countries, and the companies you want benchmarked before you build - then adjust your selection and recompile anytime from your account. You only pay for the scope you need.
What formats do I receive, and is the data editable?
Every report is readable online in full. Downloadable formats are available as optional $99 add-ons: a formatted PDF and a fully editable XLSX containing all underlying data tables - so you can re-chart, re-model, or drop any figure straight into your own deck.